Condition: Gastrointestinal Neoplasm · Sponsor: Baylor College of Medicine
The goal of this prospective, single centre, 1:1, Post Market, randomized controlled, Investigator Initiated trial, is to compare the feasibility, safety efficacy, and clinical outcomes of colonic endoscopic submucosal dissection (ESD) utilizing a novel rigidizing overtube called Pathfinder® Endoscope Overtube (Neptune Medical, Burlingame California, USA) device in comparison to conventional ESD. The research team hypothesize that with utilizing a novel rigidizing overtube the procedure time including dissection speed and closure time will be faster due to higher scope stability and greater control over the scope tip. Subsequently, the investigators anticipate lower immediate or delayed adverse events.
This description comes directly from the study's public registry record.
Michael Mercado, BS · 713-798-3606 · Michael.Mercado@bcm.edu
Sara Al Yasin, BS · 713-798-2308 · Sara.AlYasin@bcm.edu
Always discuss trial participation with your own doctor first.
| Baylor College of Medicine | Houston, Texas, United States | Recruiting |
| Baylor St. Lukes Medical Center (BSLMC) | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06134687